These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35921883)

  • 1. Association of Inhaled Corticosteroids With All-Cause Mortality Risk in Patients With COPD: A Meta-analysis of 60 Randomized Controlled Trials.
    Chen H; Deng ZX; Sun J; Huang Q; Huang L; He YH; Ma C; Wang K
    Chest; 2023 Jan; 163(1):100-114. PubMed ID: 35921883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled Corticosteroids and the Pneumonia Risk in Patients With Chronic Obstructive Pulmonary Disease: A Meta-analysis of Randomized Controlled Trials.
    Chen H; Sun J; Huang Q; Liu Y; Yuan M; Ma C; Yan H
    Front Pharmacol; 2021; 12():691621. PubMed ID: 34267661
    [No Abstract]   [Full Text] [Related]  

  • 3. Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT.
    Devereux G; Cotton S; Fielding S; McMeekin N; Barnes PJ; Briggs A; Burns G; Chaudhuri R; Chrystyn H; Davies L; Soyza A; Gompertz S; Haughney J; Innes K; Kaniewska J; Lee A; Morice A; Norrie J; Sullivan A; Wilson A; Price D
    Health Technol Assess; 2019 Jul; 23(37):1-146. PubMed ID: 31343402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials.
    Yang M; Du Y; Chen H; Jiang D; Xu Z
    Int Immunopharmacol; 2019 Dec; 77():105950. PubMed ID: 31629940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between inhaled corticosteroids and upper respiratory tract infection in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials.
    Chen H; Feng Y; Wang K; Yang J; Du Y
    BMC Pulm Med; 2020 Oct; 20(1):282. PubMed ID: 33115481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fracture risk in inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Peng S; Tan C; Du L; Niu Y; Liu X; Wang R
    BMC Pulm Med; 2023 Aug; 23(1):304. PubMed ID: 37592316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Spencer S; Karner C; Cates CJ; Evans DJ
    Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD007033. PubMed ID: 22161409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled corticosteroids versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.
    Spencer S; Evans DJ; Karner C; Cates CJ
    Cochrane Database Syst Rev; 2011 Oct; (10):CD007033. PubMed ID: 21975759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute Blood Eosinophil Counts to Guide Inhaled Corticosteroids Therapy Among Patients with COPD: Systematic Review and Meta-analysis.
    Oshagbemi OA; Odiba JO; Daniel A; Yunusa I
    Curr Drug Targets; 2019; 20(16):1670-1679. PubMed ID: 31393244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children.
    Cates CJ; Karner C
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007313. PubMed ID: 23633340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies.
    Loke YK; Cavallazzi R; Singh S
    Thorax; 2011 Aug; 66(8):699-708. PubMed ID: 21602540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis.
    Pavord ID; Lettis S; Anzueto A; Barnes N
    Lancet Respir Med; 2016 Sep; 4(9):731-741. PubMed ID: 27460163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled corticosteroids and the increased risk of pneumonia.
    Marzoratti L; Iannella HA; Waterer GW
    Ther Adv Respir Dis; 2013 Aug; 7(4):225-34. PubMed ID: 23445751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of tiotropium use and the risk of adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials.
    Yang M; Zhang Y; Cheng H; Xu Z; He J
    Eur J Clin Pharmacol; 2020 Jun; 76(6):795-805. PubMed ID: 32274526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled steroids with and without regular formoterol for asthma: serious adverse events.
    Janjua S; Schmidt S; Ferrer M; Cates CJ
    Cochrane Database Syst Rev; 2019 Sep; 9(9):CD006924. PubMed ID: 31553802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial.
    Pascoe S; Barnes N; Brusselle G; Compton C; Criner GJ; Dransfield MT; Halpin DMG; Han MK; Hartley B; Lange P; Lettis S; Lipson DA; Lomas DA; Martinez FJ; Papi A; Roche N; van der Valk RJP; Wise R; Singh D
    Lancet Respir Med; 2019 Sep; 7(9):745-756. PubMed ID: 31281061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease.
    Kew KM; Seniukovich A
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD010115. PubMed ID: 24615270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
    Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
    COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza: A systematic review and meta-analysis of randomized controlled trials. a systematic review and meta-analysis of randomized controlled trials.
    Dong YH; Chang CH; Wu FL; Shen LJ; Calverley PMA; Löfdahl CG; Lai MS; Mahler DA
    Chest; 2014 Jun; 145(6):1286-1297. PubMed ID: 24504044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood eosinophil count, a marker of inhaled corticosteroid effectiveness in preventing COPD exacerbations in post-hoc RCT and observational studies: systematic review and meta-analysis.
    Harries TH; Rowland V; Corrigan CJ; Marshall IJ; McDonnell L; Prasad V; Schofield P; Armstrong D; White P
    Respir Res; 2020 Jan; 21(1):3. PubMed ID: 31900184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.